No Data
CASI Pharmaceuticals Welcomes New CFO
CASI Pharma Taps Athenex's Daniel Lang, MD as CFO
CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announces
CASI Pharmaceuticals Names Daniel Lang Chief Financial Officer >CASI
CASI Pharmaceuticals Names Daniel Lang Chief Financial Officer >CASI
Express News | CASI Pharmaceuticals Announces Appointment of Daniel Lang, Md as CFO and Svp
CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
Express News | CASI Pharmaceuticals Shares Are Trading Higher After the Company Announced Plans to Submit an Investigational New Drug Application to the FDA for CID-103 for the Treatment of Antibody-mediated Rejection in Kidney Transplant Recipients.